These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10333054)

  • 21. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.
    Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
    J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.
    Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML
    Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.
    Wautier MP; Massin P; Guillausseau PJ; Huijberts M; Levy B; Boulanger E; Laloi-Michelin M; Wautier JL
    Diabetes Metab; 2003 Feb; 29(1):44-52. PubMed ID: 12629447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
    Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
    Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
    Sveen KA; Karimé B; Jørum E; Mellgren SI; Fagerland MW; Monnier VM; Dahl-Jørgensen K; Hanssen KF
    Diabetes Care; 2013 Nov; 36(11):3712-7. PubMed ID: 24026557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
    van Deutekom AW; Niessen HW; Schalkwijk CG; Heine RJ; Simsek S
    Eur J Endocrinol; 2008 May; 158(5):655-60. PubMed ID: 18426823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
    Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
    FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.
    Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N
    Mol Autism; 2018; 9():3. PubMed ID: 29479405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
    Kizer JR; Benkeser D; Arnold AM; Ix JH; Mukamal KJ; Djousse L; Tracy RP; Siscovick DS; Psaty BM; Zieman SJ
    Atherosclerosis; 2014 Jul; 235(1):116-21. PubMed ID: 24825341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
    Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
    Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
    Monnier VM; Sell DR; Gao X; Genuth SM; Lachin JM; Bebu I;
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35058313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
    Daimon M; Ono Y; Saito T; Yamaguchi H; Hirata A; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Kato T
    Diabetes Care; 1999 May; 22(5):877-8. PubMed ID: 10332715
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.
    Kilhovd BK; Berg TJ; Birkeland KI; Thorsby P; Hanssen KF
    Diabetes Care; 1999 Sep; 22(9):1543-8. PubMed ID: 10480523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
    O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
    J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo.
    Requena JR; Ahmed MU; Fountain CW; Degenhardt TP; Reddy S; Perez C; Lyons TJ; Jenkins AJ; Baynes JW; Thorpe SR
    J Biol Chem; 1997 Jul; 272(28):17473-9. PubMed ID: 9211892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.